UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000020596
Receipt No. R000023097
Scientific Title Proton beam therapy for hepatocellular carcinoma unsuitable for surgery or local ablative therapies
Date of disclosure of the study information 2016/01/18
Last modified on 2020/07/21 14:07:38

No. Disposal Last modified on Item of update
1 Insert 2016/01/16 19:36:52
2 Update 2016/01/22 14:37:48 Interventions/Control_1
Interventions/Control_1
3 Update 2016/06/07 12:16:17 Interventions/Control_1
Interventions/Control_1
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
4 Update 2016/06/08 19:47:38 Name of primary sponsor
Organization
Organization
Category of Funding Organization
5 Update 2016/06/16 08:59:31 Date of protocol fixation
Anticipated trial start date
6 Update 2016/06/16 09:04:40 Key secondary outcomes
7 Update 2016/06/16 19:17:33 Recruitment status
8 Update 2017/07/18 10:50:33 Organization
Division name
Organization
Division name
Organization
Division name
Institute
9 Update 2019/07/30 09:42:16 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Zip code
Address
Address
TEL

Last name of contact person

Last name of contact person
Organization
Organization
Division name
Division name
Zip code
Address
Address
TEL
Organization
Organization
Division name
Division name
Address
Address
Institute
Institute
Organization1
Tel1
Organization
Organization
Address
Address
Tel
Email
10 Update 2019/07/30 18:21:11 Organization1
Organization
Organization
11 Update 2019/07/30 18:22:25 Date of IRB
Last follow-up date
12 Update 2020/07/20 19:44:23 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
13 Update 2020/07/21 14:07:38 Number of participants that the trial has enrolled


Contact us.